How Blood Banks Ensure Safety Against Transfusion-Transmitted Infections

Blood transfusion is a life-saving procedure; however, transmitting infections through blood transfusion poses a serious risk. Therefore, ensuring blood safety is one of the essential responsibilities of blood banks to prevent transfusion-transmitted infections (TTIs). Strict procedures have been established, and high technological screening tests have been used in blood banks to avoid the transfusion of infected blood by Human Immunodeficiency Virus (HIV), Hepatitis B, and Hepatitis C.

Starting with the donation of blood to checking the health history of the donor, and examining each unit in laboratories, multiple steps are taken. Highly sensitive techniques such as nucleic acid testing (NAT) have improved the sensitivity to detect the virus in the very early period of infection. Handling, storage, labeling, and testing all contribute to blood safety.

Thorough Donor Assessment And Risk Reduction

The initial step in making the blood supply safe is careful screening of blood donors and assessment of risk before collection. Because many TTIs often appear asymptomatic in their donors, blood banks utilize careful assessment procedures. This ensures that infectious blood does not enter the donor pool.

Potential risks are evaluated based on medical history, assessment of lifestyle, and a thorough physical examination of the donor.

Some Critical Screening Measures Include:

• An extensive review of the medical history of current and previous illnesses.
• Assessing for specific, high-risk behavior related to infection.
• Identifying at-risk donors (for temporary or permanent deferral).
• Looking for symptoms of window period infections.
• Conducting physical checks (temperature, hemoglobin levels, etc).

This multi-pronged evaluation greatly minimizes the risk that infectious blood products may be collected. Together, donor screening combined with laboratory testing constitutes the most fundamental defense for preventing the transfusion of contaminated blood products.

Laboratory Testing For Transfusion Transmitted Infections (TTIs)

Laboratory testing plays an integral role in assuring blood safety and screening for transfusion-transmissible infections (TTIs). All donated units of blood are tested before being released for clinical transfusion purposes.

This substantially lowers the chances of developing infections and causes patients who receive blood to suffer significant consequences. Globally, testing has improved, with close to 99% of donations in high-income countries tested to acceptable quality standards in low-income countries.

The Infections That Are Tested For Include:

• Human immunodeficiency virus types 1 and 2
• Hepatitis B virus
• Hepatitis C virus
• Syphilis (Treponema pallidum)

Testing Is Done Using The Following Tests:

• Serological Tests- These tests the presence of antibodies against an infection or antigen against antibodies that bind to the infection.
• Nucleic Acid Test (NAT)- It detects the presence of the virus's RNA/DNA, which allows it to detect the infection very early, thereby minimizing the window period.
• Combination Assays- It detects both antibody and antigen of a particular infection, enhancing test sensitivity and specificity.

All tests above are used to screen blood,ood even if the donor does not have any sign of infection (asymptomatic donor). All reactive blood tests that do not screen negative are safely discarded. Continuous development of tests and effective quality control of the same is vital to ensuring a secure supply of blood worldwide.

Application Of Advanced Techniques For Early Detection Of Transfusion-Transmissible Infections (TTIs)

The application of sophisticated laboratory technologies greatly helps in the early detection of TTIs and the enhancement of blood safety. Among various significant developments, nucleic acid testing (NAT) is of great significance as it detects viral genetic material (RNA/DNA) and diagnoses infection earlier.

This is particularly applicable to HIV, where NAT can diagnose the infection as early as 7-11 days of exposure, thereby greatly shortening the diagnostic window period, where older assays would test negative.

Further, combination antigen-antibody immunoassay (EIA/CLIA) is commonly used and detects both viral antigens (such as HIV p24 antigen) and antibodies simultaneously and is therefore more sensitive in early detection of infections.

Antigen can be detected a few days before the appearance of antibodies, and therefore, early diagnosis. Present-day screening methods also include the use of highly sensitive serological tests in testing for hepatitis B (HBsAg), hepatitis C (antigen-antibody), and syphilis (treponemal antibodies).

Stringent Storage, Handling, And Quality Assurance Procedures

The safe and efficacious use of blood and blood components depends on the stringent use of standardised procedures for the storage, handling, and quality assurance of all blood and blood components, from the donor to the recipient in the transfusion chain.

Key Protocols:

1. Controlled Temperature Storage

Standard requirements are 2-6 °C for whole blood and red blood cells, 20-24°C with agitation for platelets, and frozen at 18 °C and below for plasma, as these temperatures are necessary to ensure that the viability of the blood components is maintained. Bacterial proliferation is also significantly reduced at these temperatures.

2. Cold Chain Management

Validated systems that maintain appropriate temperatures throughout the transportation of blood are essential.

3. Quarantine And Release System

All donated blood must undergo rigorous screening for transmissible diseases, such as HIV, Hepatitis B, Hepatitis C, and Syphilis. Blood products are only released for use if screening results are non-reactive for all infections.

4. Accurate Labeling And Traceability

Each product must be appropriately labeled and accurately documented throughout its journey in the transfusion chain.

5. Blood Component Separation And Storage

Blood components should be separated, processed, and stored, and then used for appropriate clinical purposes or targeting.

6. Quality Assurance Procedures

Validated test methods, instrument calibration, internal audits, staff training, and participation in external quality assessment schemes.

By following these rules, it is assured that the blood is kept at the necessary standards required and risks to the recipients are kept to a minimum.

Final Thoughts

The procedure is a highly detailed and multi-stage process that relies on effective donor screening and testing as well as on stringent guidelines governing all aspects of transfusions. The blood banks implement highly effective screens and tests, such as antigen-antibody assays and nucleic acid testing, after evaluating prospective donors to identify the lowest risk candidates and implementing strict blood collection practices.

Cold chain, a critical control temperature protocol, as well as adequate storage procedures, are applied during all steps of the process to ensure that any transfusion received by patients is as safe as possible to conduct and as safe as possible to receive.

Through the implementation of effective screens and tests, together with blood safety tests, the blood banks manage to minimise risks to human health. Constant improvement and adherence to global blood safety standards across all countries will lead to a healthier future.

References

1. National Institute of Health: https://www.ncbi.nlm.nih.gov/books/NBK142989/

2. Directorate General of Health Services: https://dghs.mohfw.gov.in/bts.php

3. World Health Organisation: https://www.who.int/news-room/fact-sheets/detail/blood-safety-and-availability